Your browser doesn't support javascript.
loading
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.
Caswell-Jin, Jennifer L; McNamara, Katherine; Reiter, Johannes G; Sun, Ruping; Hu, Zheng; Ma, Zhicheng; Ding, Jie; Suarez, Carlos J; Tilk, Susanne; Raghavendra, Akshara; Forte, Victoria; Chin, Suet-Feung; Bardwell, Helen; Provenzano, Elena; Caldas, Carlos; Lang, Julie; West, Robert; Tripathy, Debu; Press, Michael F; Curtis, Christina.
Afiliación
  • Caswell-Jin JL; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States.
  • McNamara K; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States.
  • Reiter JG; Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Sun R; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Hu Z; Canary Center for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, 94305, CA, USA.
  • Ma Z; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States.
  • Ding J; Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Suarez CJ; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Tilk S; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States.
  • Raghavendra A; Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Forte V; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Chin SF; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States.
  • Bardwell H; Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Provenzano E; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Caldas C; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, 94305, California, United States.
  • Lang J; Department of Genetics, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • West R; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Tripathy D; Department of Pathology, Stanford University School of Medicine, Stanford, 94305, CA, USA.
  • Press MF; Department of Biology, Stanford University, Stanford, 94305, CA, USA.
  • Curtis C; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA.
Nat Commun ; 10(1): 657, 2019 02 08.
Article en En | MEDLINE | ID: mdl-30737380
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Terapia Neoadyuvante Límite: Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Terapia Neoadyuvante Límite: Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos